| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Executive Vice President & CFO | Restricted Stock Units | 483K | $10.2M | $21.20 | Nov 21, 2024 | Direct |
| AMARIN CORP PLC\UK | SVP and CFO | Ordinary Shares | 337K | $368K | $1.09 | Aug 1, 2022 | Direct |
| CATALYST PHARMACEUTICALS, INC. | Executive Vice President & CFO | Options to purchase common stock | 462K | Nov 21, 2024 | Direct | ||
| IMPEL PHARMACEUTICALS INC | CFO | Stock Option (right to buy) | 175K | May 10, 2023 | Direct | ||
| AMARIN CORP PLC\UK | SVP and CFO | Restricted Stock Units | 95.5K | Jul 29, 2022 | Direct | ||
| IMPEL PHARMACEUTICALS INC | CFO | Restricted Stock Units (RSUs) | 47.5K | May 10, 2023 | Direct | ||
| CATALYST PHARMACEUTICALS, INC. | Executive Vice President & CFO | Common Stock, par value $0.001 per share | 0 | $1.13 | Jan 1, 2024 | Direct | |
| CinCor Pharma, Inc. | EVP & Chief Financial Officer | Common Stock | 0 | $28.75 | Feb 24, 2023 | Direct | |
| CinCor Pharma, Inc. | EVP & Chief Financial Officer | Stock Option (Right to Buy) | 0 | Feb 24, 2023 | Direct | ||
| IMPEL PHARMACEUTICALS INC | CFO | No securities beneficially held. | 0 | May 10, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CPRX | CATALYST PHARMACEUTICALS, INC. | Nov 21, 2024 | 2 | $0 | 4 | Nov 25, 2024 | Executive Vice President & CFO |
| CPRX | CATALYST PHARMACEUTICALS, INC. | Jan 1, 2024 | 0 | $0 | 3 | Jan 3, 2024 | Executive Vice President & CFO |
| IMPL | IMPEL PHARMACEUTICALS INC | May 10, 2023 | 2 | $0 | 4 | May 12, 2023 | CFO |
| IMPL | IMPEL PHARMACEUTICALS INC | May 10, 2023 | 0 | $0 | 3 | May 12, 2023 | CFO |
| CINC | CinCor Pharma, Inc. | Feb 24, 2023 | 2 | $0 | 4 | Feb 24, 2023 | EVP & Chief Financial Officer |
| CINC | CinCor Pharma, Inc. | Jan 26, 2023 | 1 | $0 | 4 | Jan 30, 2023 | EVP & Chief Financial Officer |
| CINC | CinCor Pharma, Inc. | Nov 4, 2022 | 2 | $0 | 4 | Nov 8, 2022 | EVP & Chief Financial Officer |
| CINC | CinCor Pharma, Inc. | Nov 4, 2022 | 0 | $0 | 3 | Nov 8, 2022 | EVP & Chief Financial Officer |
| AMRN | AMARIN CORP PLC\UK | Jul 29, 2022 | 4 | -$62.4K | 4 | Aug 2, 2022 | SVP and CFO |
| AMRN | AMARIN CORP PLC\UK | Feb 28, 2022 | 3 | -$20.3K | 4 | Mar 2, 2022 | SVP and CFO |
| AMRN | AMARIN CORP PLC\UK | Feb 4, 2022 | 2 | $0 | 4 | Feb 8, 2022 | SVP and CFO |
| AMRN | AMARIN CORP PLC\UK | Jan 31, 2022 | 3 | -$17.9K | 4 | Feb 2, 2022 | SVP and CFO |
| AMRN | AMARIN CORP PLC\UK | Dec 31, 2021 | 3 | -$85K | 4 | Jan 4, 2022 | SVP and CFO |
| AMRN | AMARIN CORP PLC\UK | Aug 31, 2021 | 7 | -$16.7K | 4 | Sep 2, 2021 | SVP and CFO |
| AMRN | AMARIN CORP PLC\UK | Aug 12, 2021 | 5 | -$348K | 4 | Aug 13, 2021 | SVP and CFO |
| AMRN | AMARIN CORP PLC\UK | Aug 2, 2021 | 1 | $0 | 4 | Aug 4, 2021 | SVP and CFO |
| AMRN | AMARIN CORP PLC\UK | Jul 30, 2021 | 7 | -$12.5K | 4 | Aug 3, 2021 | SVP and CFO |
| AMRN | AMARIN CORP PLC\UK | Jun 30, 2021 | 7 | -$13.5K | 4 | Jul 2, 2021 | SVP and CFO |
| AMRN | AMARIN CORP PLC\UK | May 28, 2021 | 7 | -$13.6K | 4 | May 28, 2021 | SVP and CFO |